𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma

✍ Scribed by Tsuyoshi Saito; Makoto Nishimura; Hiroshi Yamasaki; Ryuichi Kudo


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
311 KB
Volume
97
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND

Loss of E‐cadherin expression is associated with aberrant 5′ CpG island methylation in various tumors.

METHODS

The authors analyzed the methylation status and immunohistochemical expression of E‐cadherin in 142 endometrial tissues, consisting of 21 normal endometria, 17 endometrial hyperplasias, and 104 endometrial carcinomas.

RESULTS

All normal endometria and endometrial hyperplasias showed positive staining of E‐cadherin, and methylation of the E‐cadherin gene was not detected in any samples. In endometrial carcinoma, the positive ratio of methylation was higher and was associated with tumor dedifferention and myometrial invasion. In G1 endometrial adenocarcinomas, 66.7% showed positive staining and 33.3% showed heterogeneous staining. Methylation of the E‐cadherin gene was detected in 15.6%. In G2 tumors, 19.0% showed positive staining, 69.0% showed heterogeneous staining and 11.9% showed negative staining. Methylation of the E‐cadherin gene was found in 50.0%. In G3 tumors, 9.1% showed positive staining, 54.5% showed heterogeneous staining and 36.3% showed negative staining. Methylation of the E‐cadherin gene was found in 81.8% of the tumors. Of the samples with no‐myometrial invasion, 23.1% had methylation. In those with invasion in less than half of the myometrium, 28.6% did and in those with invasion of half or more of the myometrium, 55.6% had methylation. Of samples that did not have lymph node metastasis, 33.7% had methylation, whereas of samples that had lymph node metastasis, 60.0% had methylation.

CONCLUSIONS

This is the first report to analyze methylation of the E‐cadherin gene promoter of endometrial carcinoma and the evidence suggests that methylation of the E‐cadherin gene occurs in association with the acquisition of invasive capacity. Cancer 2003;97:1002–9. © 2003 American Cancer Society.

DOI 10.1002/cncr.11157


📜 SIMILAR VOLUMES


Promoter hypermethylation of fibulin 1 g
✍ Mitsuro Kanda; Shuji Nomoto; Yukiyasu Okamura; Masamichi Hayashi; Mitsuhiro Hish 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB

## Abstract Hepatocellular carcinoma (HCC) is one of the most common cancers world‐wide but the molecular mechanisms that underlie hepatocarcinogenesis are not fully determined. On the same surgical sample with HCC, we performed microarray‐based gene expression profiling and karyotype analysis usin

Promoter hypermethylation profile of tum
✍ Muthusamy Viswanathan; Nobuo Tsuchida; Govindaswamy Shanmugam 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 211 KB

## Abstract Aberrant promoter hypermethylation of tumor‐associated genes leading to their inactivation is a common event in many cancer types. Using a sensitive restriction‐multiplex PCR method, we studied the promoter hypermethylation profile of the __p16, p15, hMLH1, MGMT__ and __E‐cad__ genes in

Genetic polymorphism in the 3′-untransla
✍ Yan Li; Yuanjia Tang; Rongmiao Zhou; Donglan Sun; Yanan Duan; Na Wang; Zhifeng C 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 1 views

## Abstract The genetic polymorphisms in E‐cadherin gene (__CDH1__) may affect invasive/metastatic disease development by altering gene transcriptional activity. In this paper, we investigated the effect of 3′‐UTR +54C/T polymorphism (rs1801026) in __CDH1__ gene on the risk and progression of sever